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Peripheral nerves are characterised by the ability to regenerate after injury. Schwann cell
activity is fundamental for all steps of peripheral nerve regeneration: immediately after
injury they de-differentiate, remove myelin debris, proliferate and repopulate the injured
nerve. Soluble Neuregulin1 (NRG1) is a growth factor that is strongly up-regulated and
released by Schwann cells immediately after nerve injury. To identify the genes regulated
in Schwann cells by soluble NRG1, we performed deep RNA sequencing to generate a
transcriptome database and identify all the genes regulated following 6 h stimulation of
primary adult rat Schwann cells with soluble recombinant NRG1. Interestingly, the gene
ontology analysis of the transcriptome reveals that NRG1 regulates genes belonging
to categories that are regulated in the peripheral nerve immediately after an injury. In
particular, NRG1 strongly inhibits the expression of genes involved in myelination and in
glial cell differentiation, suggesting that NRG1 might be involved in the de-differentiation
(or “trans-differentiation”) process of Schwann cells from a myelinating to a repair
phenotype. Moreover, NRG1 inhibits genes involved in the apoptotic process, and
up-regulates genes positively regulating the ribosomal RNA processing, thus suggesting
that NRG1 might promote cell survival and stimulate new protein expression. This
in vitro transcriptome analysis demonstrates that in Schwann cells NRG1 drives the
expression of several genes which partially overlap with genes regulated in vivo after
peripheral nerve injury, underlying the pivotal role of NRG1 in the first steps of the nerve
regeneration process.
Keywords: Neuregulin1, Schwann cells, peripheral nerve injury, RNA deep sequencing, de-differentiation,
demyelination, transcription, genetic
INTRODUCTION
Schwann cells represent the glial component of the peripheral nervous system. As well as supporting
axonal function in a physiological status, they play a critical role during the degenerative and
the regenerative processes activated after nerve injury (Namgung, 2014; Gordon, 2016; Jessen
and Mirsky, 2016). A severe damage to the nerve tissue determines the loss of axon-Schwann cell
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contact with subsequent change in Schwann cell phenotype.
Schwann cell de-differentiation occurs within 48 h after nerve
injury and is driven by changes in gene expression with
the down-regulation of genes related to myelination and node
organisation, and the up-regulation of regeneration associated
genes (RAG), such as growth factor receptors and adhesion
molecules (Pereira et al., 2012; Jessen and Mirsky, 2016).
De-differentiated Schwann cells isolate lipid droplets, composed
by myelin, and participate to their degradation in the distal
nerve. Few days after injury they proliferate and align to
form the Büngner bands, a tubular structure that physically
supports re-growing axons (Fawcett and Keynes, 1990; Ide,
1996). Moreover, Schwann cells are the source of growth
factors that stimulate axon growth and create the appropriate
supportive environment for axonal elongation (Hopker et al.,
1999; Madl and Heilshorn, 2015). In the later phase of the
regenerative process, they differentiate into myelinating and
non-myelinating Schwann cells, determining the recovery of
nerve morphology.
Schwann cell de-differentiation, proliferation and survival are
regulated by the action of several growth factors. Among them,
Neuregulin 1 (NRG1) increasingly attracted the attention for
its involvement in several aspects of Schwann cell behaviour.
NRG1 is a growth factor characterised by multiple isoforms
thanks to alternative splicing (Mei and Xiong, 2008). Both
soluble and transmembrane isoforms are present in peripheral
nerves: transmembrane isoforms are expressed by neurons and
are involved in myelin thickness regulation (Michailov et al.,
2004; Taveggia et al., 2005), whereas soluble NRG1 isoforms are
released both by Schwann cells and neurons and are thought
to control Schwann cell survival, migration, de-differentiation,
as well as the myelination process (Birchmeier and Nave, 2008;
Fricker and Bennett, 2011; Stassart et al., 2013). NRG1 is strongly
and transiently up-regulated in the distal stump immediately
after nerve injury (Carroll et al., 1997; Stassart et al., 2013; Ronchi
et al., 2016), suggesting a major role played by it in the response
to nerve injury and in the nerve regeneration process.
Despite cellular effects induced by NRG1 stimulation, such
as cell survival and migration, have been widely investigated
(Dong et al., 1995; Zanazzi et al., 2001; Atanasoski et al., 2006;
Birchmeier and Nave, 2008; Wakatsuki et al., 2014) and single
genes have been demonstrated to be regulated by NRG1 in
Schwann cells (Freidin et al., 2009; Iruarrizaga-Lejarreta et al.,
2012; Sonnenberg-Riethmacher et al., 2015), a deep sequencing
analysis of the genes modulated by NRG1 a few hours after
stimulation has not yet been performed. Here, we present a global
transcriptome analysis, aimed to identify the genes regulated
in vitro by soluble NRG1 stimulation in primary rat Schwann cell
culture.
We chose to analyse the transcriptome 6 h after
NRG1 stimulation, to detect the early regulated genes and
compare their expression pattern with the genes regulated in vivo
after injury, where soluble NRG1 release and transcription are
induced soon (Carroll et al., 1997; Guertin et al., 2005; Stassart
et al., 2013; Ronchi et al., 2016; Yu et al., 2016) and a strong gene
expression regulation is detectable between 6 h and 24 h (Yi
et al., 2017).
MATERIALS AND METHODS
Schwann Cell Primary Culture
To obtain Schwann cell primary cultures, sciatic nerves from
adult female Wistar rats (ENVIGO, Milan, Italy) were isolated
and harvested. This study was carried out in accordance
with the recommendations of the Council Directive of the
European Communities (2010/63/EU), the National Institutes
of Health guidelines, and the Italian Law for Care and Use of
Experimental Animals (DL26/14). The protocol was approved by
the Italian Ministry of Health and the Bioethical Committee of
the University of Torino. Conformed measures were taken into
account to reduce the number of animals used and to minimise
animal pain and discomfort.
Schwann cells from sciatic nerves were purified and cultured
as previously described (Gnavi et al., 2015). Primary Schwann
cells were routinely cultured on poly-L-lysine (PLL, Sigma)-
coated plate, in complete medium consisting of DMEM (Sigma
#D5671) supplemented with 10% heat-inactivated foetal bovine
serum (FBS, Invitrogen), 100 units/ml penicillin, 0.1 mg/ml
streptomycin, 1 mM sodium pyruvate, 2 mM L-glutamine, 8 nM
recombinant soluble NRG1β1 (#396-HB, R&D Systems), 10 µM
forskolin (Sigma) and incubated at 37◦C in 5% CO2.
Schwann cells were cultured in the presence of 10 µM
forskolin, because Schwann cell primary cultures display
dedifferentiated cell features, having lost their axonal contact
(Morrissey et al., 1991), but they can be induced to reacquire
the differentiated phenotype (i.e., high myelin gene expression)
by exposure to agents increasing the intracellular levels of cAMP
(Sobue et al., 1986).
Schwann Cell Stimulation and RNA
Isolation
Confluent Schwann cells were starved overnight in starving
medium consisting of DMEM (Sigma #D5671) supplemented
with 2% heat-inactivated FBS, 100 units/ml penicillin, 0.1 mg/ml
streptomycin, 1 mM sodium pyruvate, 2 mM L-glutamine,
and 10 µM forskolin and then stimulated for 6 h with
10 nM recombinant soluble NRG1β1 (#396-HB, R&D Systems).
Control mock samples were stimulated with the same volume
of ligand resuspension buffer (PBS containing 1% bovine
serum albumin/BSA, Sigma). After the stimulation, total RNA
was isolated using TRIzol reagent (Invitrogen), following
manufacturer’s instructions.
Schwann cell stimulation was performed in biological
triplicate for deep sequencing analysis and in biological triplicate
for gene expression validation through quantitative real time
PCR analysis.
Biological triplicates were carried out using independent
preparation of cells.
Deep RNA Sequencing
Deep RNA sequencing was performed on three mock samples
and three stimulated samples obtained in three independent
experiments. RNA quality was assessed on an Agilent
2100 Bioanalyzer. All samples had RIN ≥9. For RNA-Seq
library preparation, approximately 2 µg of total RNA were
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subjected to poly(A) selection and libraries were prepared using
the TruSeq RNA Sample Prep Kit (Illumina) following the
manufacturer’s instructions. Sequencing was performed on the
Illumina NextSeq 500 platform.
The RNA Sequencing data have been deposited in the
National Center for Biotechnology Information (NCBI) Gene
Expression Omnibus (GEO), accessible through GEO Series
accession number GSE104324.
Analysis of RNA-Seq Data
Reads were mapped to the Rattus norvegicus rn5 reference
assembly using TopHat v2.0.10 (Kim et al., 2013) and counts
were generated using htseq and the refseq transcriptome. Genes
with RPKM >1 in all three replicates were considered expressed
in each condition. Differential expression was determined
with DESeq2 (Love et al., 2014) with default parameters,
implementing a paired design by using the biological replicate
as covariate. Genes with adjusted P ≤ 0.01 and absolute log2
fold change >1 (fold change <0.5 and >2) were considered
differentially expressed. Gene Ontology enrichment analysis was
performed with ClusterProfiler (Yu et al., 2012) with a cutoff of
P adjusted <0.1 (Supplementary Table S2). The analysis was
performed using the gene ontology annotation of the mouse
orthologs of our genes, due to the better functional annotation
of the mouse genome.
Analysis of Public Gene Expression
Datasets
Two gene expression datasets, obtained from injured sciatic
nerve samples, were down-loaded from GEO as normalised
expression values.
#GSE22291 series corresponds to microcrushed adult mice
sciatic nerves 3 and 7 days after injury, compared with control
nerves; samples were hybridised to GeneChip Mouse Genome
430 2.0 Array (Affymetrix), platform GPL1261 (Barrette et al.,
2010). Genes with adjusted P < 0.001 and absolute log2 fold
change >1 were considered differentially expressed.
#GSE33454 series corresponds to cut adult mice sciatic
nerves 1 and 5 days after injury, compared with sham control
sciatic nerves; samples were analysed on Illumina MouseRef-8
v2.0 expression beadchip, platform GPL6885 (Kim et al., 2012).
No biological replicates are available; genes with absolute log2
fold change >1 were considered differentially expressed.
Genes expressed 7 days after adult mice sciatic nerve cut,
compared with contralateral uninjured nerves, were downloaded
from the Supplementary Material of the article of Arthur-Farraj
et al. (2017), where, to generate 100 bp paired-end reads, three
libraries were run on a single lane of the HiSeq 2000 platform
(Illumina). All selected genes have an adjusted P value < 0.05;
those with an absolute log2 fold change >1 were considered
differentially expressed.
Genes expressed 0.5 h, 1 h, 6 h, 12 h after adult mice sciatic
nerve cut, compared with sham control sciatic nerves, were
downloaded from the Supplementary Material of the article of Yi
et al. (2017); samples were hybridised to Affymetrix GeneChip
Hybridisation Oven 640. Genes with adjusted P < 0.05 and
absolute log2 fold change >1 were considered differentially
expressed.
cDNA Preparation and Quantitative
Real-Time PCR (qRT-PCR)
To validate the deep RNA sequencing analyses, 0.5 µg total RNA
were retro-transcribed in a 25 µl reaction volume containing
1×RT buffer, 0.1µg/µl BSA, 7.5µMRandomHexamer Primers,
1 mM deoxynucleoside triphosphate (dNTPs), 0.05% Triton,
40U RIBOlock and 200U RevertAidr Reverse Transcriptase (all
ingredients were purchased by Thermo Scientific). The reaction
was performed following the manufacturer’s instructions.
qRT-PCR was performed by ABI Prism 7300 (Applied
Biosystems, Life Technologies Europe BV) detection system.
The cDNA was diluted 10 fold in nuclease-free water, and
5 µl (corresponding to 15 ng starting RNA) were analysed in
a 20 µl reaction volume containing 1× iTaq Universal SYBR
Green Supermix (BioRad) with 300 nM forward and 300 nM
reverse primers. Dissociation curves were routinely performed
to confirm the presence of a single peak corresponding to the
required amplicon. Analyses were performed in technical and
biological triplicate. For each experiment the average of mock
samples was used as a calibrator. The threshold cycle (Ct) values
were normalised to TATA Binding Protein (TBP), a general RNA
polymerase II transcription factor, which has been shown to
be a good housekeeping gene without retro-pseudogenes in the
genome and with different exons to design forward and reverse
primers separated by an intron (Vandesompele et al., 2002).
Expression data were shown as −∆∆CT to compare qRT-PCR
results with deep sequencing data expressed as log2 (fold change).
TABLE 1 | List of primers used for quantitative real time PCR (qRT-PCR) analysis to validate deep sequencing results.
Gene Accession number Forward primer (5′–3′) Reverse primer (5′–3′) Amplicon size
Atf3 NM_012912.2 CACCATCAACAACAGACCTCTGGAG CCGCCGCCTCCTTTTTCTCTC 85 bp
Bmp7 NM_001191856.2 CGTCAACCTAGTGGAGCACGAC GTCACCGCCTCTCCCTCGG 102 bp
Egr2 NM_053633.1 GACCATCTTCCCCAATGGTGAACTG GATATGGGAGATCCAAGGGCCTCTTC 119 bp
Hmga2 NM_032070.1 CGCCACAGAAGCGAGGACG GGGGCTCTTGTTCTTGCTGCC 113 bp
Inhba NM_017128.2 CGGAGATCATCACCTTTGCCGAG CAGGAAGAGCCAGACTTCTGCAC 116 bp
Mag NM_017190.4 CGCCTTCAACCTGTCTGTGGAGT GCCACGGAGGGTTCCGG 120 bp
Mbp NM_017026.2 GGACCCAAGATGAAAACCCAGTAGTCC CCTTTCCTTGGGATGGAGGGGG 81 bp
Pmp22 NM_017037.1 CCTTGGGAGCCGTCCAGC GGACGCTGAAGATGACAGACAGGATC 69 bp
Shc4 NM_001191065.1 CACTTGGGAAAGGGAGGAGGTCC CACATCTGCAATGCCGCCTG 112 bp
Tbp NM_001004198.1 TAAGGCTGGAAGGCCTTGTG TCCAGGAAATAATTCTGGCTCATAG 68 bp
Vegfc NM_053653.1 CGTCGCCGCCTTCGAGTC GCTCATCTACACTGGACACAGACCG 122 bp
Frontiers in Molecular Neuroscience | www.frontiersin.org 3 May 2018 | Volume 11 | Article 157
El Soury et al. Neuregulin1 Down-Regulates Myelination Genes
Primers were designed using Annhyb software1 and synthesised
by BMR Genomics. Primer sequences are reported in Table 1.
Statistical Analysis
For qRT-PCR data, statistical analysis between two groups (mock
and treated samples) was performed in GraphPad Prism 5 by
the two-tailed Student’s t-test. All data were expressed as mean
+ standard error (SEM).
RESULTS
Several Genes in Schwann Cells Are
Regulated By Soluble NRG1 Stimulation
To identify the genes regulated early by soluble NRG1, deep
sequencing analysis was applied on RNA samples obtained from
Schwann cells stimulated 6 h with 10 nM recombinant soluble
NRG1β1 (from here on called NRG1) and mock stimulated cells,
in three independent biological replicates. Preliminary assays had
been previously performed to verify that treatment with 10 nM
NRG1 is able to stimulate ErbB3, AKT, ERK phosphorylation
(data not shown).
We identified the genes expressed in the biological triplicate
by mock Schwann cells (11312, 10810, 11142) and by Schwann
cells following NRG1 stimulation (11239, 10811, 11197).
Comparing the NRG1 stimulated cells with the mock cells,
190 genes were significantly differentially expressed: 101 up-
regulated, 89 down-regulated (with a |log2fold change|>1,
corresponding to a fold change <0.5 and >2, with a P adjusted
≤0.01), with 93% of the differentially expressed genes having an
adjusted P value< 0.001.
A heat map of the 50 most differentially regulated genes is
shown in Figure 1, while the full list of differentially expressed
genes is shown in Supplementary Table S1.
To validate deep RNA sequencing data, the expression profile
of 10 selected genes was analysed by quantitative real time PCR
performed on RNA samples obtained from mock Schwann cells
or stimulated 6 h with 10 nM NRG1. Validation was performed
on three independent biological replicates different from those
used for the deep sequencing.
Five up- and five down-regulated genes were chosen
based on their adjusted P values or their annotated Gene
Ontology categories. Among them, eight were strongly regulated
(corresponding to 4.2% of differentially regulated genes),
two weakly; all of them were significantly validated. Inhba,
Hmga2, Bmp7, Shc4, Vegfc were representative for up-regulated
genes, Atf3, Pmp22, Egr2, Mag, Mbp were representatives for
down-regulated genes. As shown in Figure 2, the expression
profile of these genes was consistent in both analyses.
NRG1 Strongly Down-Regulates
Myelination Genes
In order to assign the differentially regulated genes to
their functions, Gene Ontology analysis was performed using
1http://www.bioinformatics.org/annhyb/
ClusterProfiler package, focusing the attention on the biological
processes (BP).
Genes up-regulated following NRG1 stimulation were
enriched in two annotation categories: 11 genes belong to
the category of ‘‘rRNA metabolic processes’’ (Padj = 0.0001),
four genes belong to ‘‘negative regulation of Notch signalling
pathway’’ (Padj = 0.0219); the complete list of these up-regulated
genes is shown in Table 2.
Due to redundancy in gene ontology annotations, here we
show a selected list of up-regulated and down-regulated BP;
the complete list of BP, Molecular Functions (MF) and Cellular
Components (CC) is shown in Supplementary Table S2.
Functional enrichment is stronger for down-regulated genes.
‘‘Myelination’’ (Padj = 0.0043) is the most enriched category
among down-regulated genes, with seven genes down-regulated
in response to NRG1. The following categories are ‘‘Positive
regulation of ion transmembrane transport’’ (Padj = 0.0065) with
six regulated genes, ‘‘Glial cell differentiation’’ (Padj = 0.0090)
with eight genes, ‘‘Regulation of membrane potential’’
(Padj = 0.0105) with nine genes, ‘‘Bleb assembly’’ with
three genes (Padj = 0.0236). Finally, ‘‘Positive regulation of
apoptotic process’’ (Padj = 0.0803) with 11 genes, ‘‘Macrophage
activation’’ (Padj = 0.0956) with three. The complete list of these
down-regulated genes is shown in Table 2.
Several Genes Regulated By
NRG1 Overlap With Genes Regulated
Following Nerve Injury
As expected, the genes regulated by NRG1 are annotated in
categories that are related to Schwann cell response following
an injury. To identify which of these genes are also regulated
after a nerve injury, expression profiling data obtained from
injured sciatic nerve samples were downloaded from GEO or
from Supplementary Information of published articles.
To investigate gene expression in the first hours after injury,
genes regulated by NRG1 (101 up- and 89 down-regulated) were
compared with genes differentially expressed 0.5 h, 1 h, 6 h,
12 h after nerve cut (Yi et al., 2017). This analysis shows that
after 0.5 and 1 h there are not differentially expressed genes in
common with our data. After 6 h, six up-regulated genes are in
common, after 12 h, seven up-regulated and two down-regulated
genes are in common with our data (Figure 3).
Then, to investigate gene expression in the following phase
after injury, genes regulated by NRG1 were compared with genes
regulated 1 and 5 days after nerve cut (Kim et al., 2012), 3 and
7 days after nerve microcrush (Barrette et al., 2010), 7 days after
nerve cut (Arthur-Farraj et al., 2017). These data show that in the
first week of injury 54% of NRG1 down-regulated genes and 40%
of NRG1 up-regulated genes are also regulated after nerve injury:
13 up-regulated and 9 down-regulated 1 day after nerve cut;
23 up-regulated and 40 down-regulated 3 days after nerve
microcrush; 8 up-regulated and 11 down-regulated 5 days after
nerve cut; 16 up-regulated and 26 down-regulated 7 days after
nerve microcrush. Many genes show the same regulation at
different time points. Intriguingly, few genes (9 up- and 12 down-
regulated) show an opposite expression regulation, two genes are
down-regulated 1 day after injury and after NRG1 treatment,
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FIGURE 1 | Heatmap of the 50 most differentially regulated genes in Schwann cells. The heatmap shows the biological triplicate expression of the first
50 differentially expressed genes in Schwann cells stimulated with 10 nM NRG1β1 based on the obtained P value. “Mock” corresponds to samples treated with the
vehicle, “treated” corresponds to samples treated with NRG1β1. Colour intensity reflects the expression level and represents the log2 (RPKM + 1) of the observed
gene in each sample (RPKM, Reads Per Kilo base of transcript per Million mapped reads).
but later their expression is up-regulated. The complete list of
genes regulated both by NRG1 and by nerve injury is shown in
Figure 4.
DISCUSSION
Schwann cells, the main glial cells in the peripheral nervous
system, play a key role both during development and following
nerve injury, being responsible of axonal ensheathment,
myelination and post-injury nerve repair (Jessen et al., 2015;
Taveggia, 2016). Different factors and signalling pathways are
involved in the control of these activities (Pereira et al., 2012;
Boerboom et al., 2017).
It has been shown by others (Carroll et al., 1997; Stassart et al.,
2013) and our research group (Ronchi et al., 2016) that different
isoforms of soluble NRG1 are strongly up-regulated after injury.
Moreover, in transgenic mice expressing soluble NRG1 in
postnatal motoneurons and DRG neurons, but missing NRG1 in
Schwann cells (Thy1.2-NRG1-I-β1a X Dhh-Cre X Nrg1loxP/loxP),
nerve regeneration after crush is inefficient (Stassart et al., 2013),
thus showing that soluble Nrg1 expressed by neurons does not
completely compensate for the lack of NRG1 expression in
Schwann cells, thus suggesting that soluble NRG1 plays a key role
for their activity after injury.
Schwann cells represent 90% of the total cell number in
uncut nerves, 70% in injured nerves, the majority of the rest
being fibroblasts, macrophages and perineural cells (Arthur-
Farraj et al., 2017). The role of the latter must not be denied,
but here we focused our attention on Schwann cells, the main
non-neuronal cell type in the peripheral nerve, to investigate the
role of soluble NRG1 in their activity.
To this aim, by RNA deep sequencing, we carried out a
transcriptome analysis to identify the genes regulated in vitro in
Schwann cells following NRG1 stimulation.
Then, we compared this list of differentially regulated genes
with the genes expressed in vivo in the injured nerve to find
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FIGURE 2 | Deep RNA sequencing validation through quantitative real
time-PCR (qRT-PCR). Validation of 10 representative gene transcripts was
performed by qRT-PCR, showing that the behaviour of five up- and five
down-regulated genes was consistent in both techniques. log2 fold change
(corresponding to −∆∆CT for qRT-PCR) obtained comparing samples treated
with Neuregulin1 (NRG1) with mock treated samples is shown, both for deep
sequencing, both for qRT-PCR data.
common regulated genes, conscious of the fact that in the
injured nerve environment, besides Schwann cells, there are
other different cell types, and that there are other released factors
besides soluble NRG1.
A stringent analysis was performed to select genes
significantly regulated in vitro by NRG1 stimulation with a
2-fold threshold and a highly significant adjusted P value
(≤0.01). As expected, NRG1 stimulation induces differential
gene expression in Schwann cells. Applying gene ontology, the
regulated genes were categorised into specific groups based
on the relevant BP, CC and MF. We focused our attention on
the BP; after eliminating redundant categories, down-regulated
genes were enriched in seven categories, while up-regulated
genes were enriched in two.
Enriched gene categories are consistent with the phenotypic
changes occurring in Schwann cells after injury: the portion of
the nerve distal to the injury undergoes Wallerian degeneration,
a complex process characterised by axonal degeneration
and degradation of myelin sheath, followed by debris
phagocytosis by Schwann cells and macrophages (Dubovy,
2011). Demyelination is an important step during Wallerian
degeneration, starting with fragmentation of the myelin sheath
into small ovoid-like structures (Ghabriel and Allt, 1979)
and with the down-regulation of myelin genes (Jessen and
Mirsky, 2008). Because NRG1 receptor activation is sufficient
to initiate Schwann cell demyelination (Guertin et al., 2005),
it has been suggested that NRG1 might play a key role in the
de-differentiation process (Fricker and Bennett, 2011; Shin et al.,
2013).
Both myelinating and non-myelinating (Remak) Schwann
cells participate to Wallerian degeneration and trans-
differentiate into a repair phenotype specialised to promote
nerve regeneration (Jessen and Mirsky, 2016). Accordingly,
when we consider gene expression analysis in vivo, both
myelinating and non-myelinating Schwann cells contribute to
the transcriptome, as well as in vitro, where primary cultures
obtained from sciatic nerves contain both myelinating and
non-myelinating cells.
When we analysed the enriched categories of differentially
expressed genes in response to NRG1 stimulation, we found
that ‘‘myelination’’ is the most enriched category among
down-regulated genes, with several genes known to be involved
in the myelination process down-regulated (Pmp22, Serinc5,
TABLE 2 | Biological process (BP) enriched categories obtained by Gene Ontology analysis.
Biological process enriched category Down-regulated genes P adjusted List of genes
Myelination 7 0.004263845 Pmp22, Serinc5, Ndrg1, Fa2 h, Mal, Rxrg, Egr2
Positive regulation of ion transmembrane transport 6 0.006544373 Dmd, Hspa2, Snca, P2rx7, Atp1b2, Hcn1
Glial cell differentiation 8 0.008986003 Gpr37l1, Ndrg1, Dmd, Epha4, Fa2 h, Egr2, Ntrk3, Lingo1
Regulation of membrane potential 9 0.010459252 Dmd, Snca, P2rx7, Grik2, Atp1b2, Kcnk5, Cldn19, Slc26a2,
Hcn1
Bleb assembly 3 0.023620351 Emp2, Pmp22, P2rx7
Positive regulation of apoptotic process 11 0.080348376 Atf3, Bmf, Gadd45a, Ctsc, Snca, P2rx7, Grik2, Mal, Fbxo32,
Ntrk3, Sept4
Macrophage activation 3 0.095570035 Cd200, Snca, Adgrf5
Biological process enriched category Up-regulated genes P adjusted List of genes
rRNA metabolic processes 11 0.000126 Fbl, Bop1, Wdr46, Nop56, Ddx21, Nat10, Bysl, Rrp9, Nop2,
Emg1, Rrp15
Negative regulation of Notch signalling pathway 4 0.02191 Bmp7, Dlk1, Lfng, Dll4
Because of redundancy in gene ontology annotations, only a selected list of up-regulated and down-regulated biological processes is shown (all enriched categories of
biological processes, molecular functions and cellular components are shown in Supplementary Table S2).
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FIGURE 3 | Genes differentially regulated in vitro by NRG1 compared with
0.5–12 h injured nerves. Genes significantly regulated following
NRG1 stimulation (101 up- and 89 down-) were compared with genes
regulated 0.5 h, 1 h, 6 h, and 12 h after sciatic nerve cut (Yi et al., 2017).
Among them, seven up-regulated and two down-regulated show the same
regulation behaviour after 12 h.
Ndrg1, Fa2h, Mal, Rxrg and Krox20/Egr2), thus suggesting
that myelination genes were expressed by myelinating Schwann
cells undergoing trans-differentiation, while the enriched
down-regulated category ‘‘glial cell differentiation’’ reflects gene
expression of both myelinating and non-myelinating Schwann
cells.
The fact that NRG1 inhibits myelination genes evokes
literature data showing that the transcription factor c-Jun
negatively regulates myelination (Parkinson et al., 2008),
down-regulating genes essential in the myelination program,
such as the zinc finger transcription factor Krox20/Egr2 (Warner
et al., 1998), which in turn has been shown to inhibit c-Jun
expression in a reciprocal negative feed-back loop (Parkinson
et al., 2004).
We found that also soluble NRG1 inhibits
Krox20/Egr2 expression, thus suggesting that NRG1—inhibiting
Krox20/Egr2—might contribute to stimulate c-Jun expression.
Accordingly, it has been shown in vitro that NRG1 treatment
stimulates c-Jun expression (Syed et al., 2010) and
phosphorylation (Parkinson et al., 2004). Further analyses
in vitro and in vivo will be necessary to better investigate the
cross-talk between c-Jun and NRG1.
Genes annotated in categories like ‘‘positive regulation of
apoptotic process’’ and ‘‘bleb assembly’’ are also down-regulated,
suggesting that NRG1 supports Schwann cell survival following
nerve injury.
NRG1 stimulation of Schwann cells showed a
down-regulation of genes annotated in the enriched category
FIGURE 4 | Genes differentially regulated in vitro by NRG1 compared with
1–7 days injured nerves. Genes significantly regulated following
NRG1 stimulation (101 up- and 89 down-) were compared with genes
regulated 1 and 5 days after sciatic nerve cut (Kim et al., 2012), 3 and 7 days
after sciatic nerve microcrush (Barrette et al., 2010), and 7 days (∗) after sciatic
nerve cut (Arthur-Farraj et al., 2017). Among them, 40 up-regulated and 46
down-regulated show the same regulation behaviour at different time points
after injury, 9 up-regulated and 12 down-regulated show an opposite
behaviour, two down-regulated genes show a mixed behaviour.
‘‘regulation of macrophage activation’’, such as Cd200 and Snca.
Macrophages are recruited to the nerve injured site to eliminate
fragmented myelin debris and dead cells (Dubovy, 2011).
Cd200 is expressed in node of Ranvier and Schmidt-Lanterman
incisures and is down-regulated following nerve injury (Chang
et al., 2011). It has been suggested that Cd200 down-regulation
might facilitate macrophage infiltration through the node of
Ranvier to eliminate degenerated axons and myelin debris
(Chang et al., 2011). Also Synuclein α (Snca) is localised at nodes
of Ranvier and Schmidt-Lanterman incisures, is up-regulated
during myelination and down-regulated after nerve injury
(D’Antonio et al., 2006) and might be involved in macrophage
infiltration. Indeed, it has been shown that following sciatic
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nerve transection, transgenic mice over-expressing Snca show
a lower number of invading macrophages (Siebert et al.,
2010).
Two categories of up-regulated genes are enriched in response
to NRG1 stimulation: ‘‘genes responsible for rRNA metabolic
processes’’ and ‘‘negative regulation of Notch signalling
pathway’’. The up-regulation of the former contributes to the
synthesis and production of new proteins and molecules needed
to guide Wallerian degeneration and nerve regeneration.
Notch is a transmembrane receptor that acts as a negative
regulator of myelination: it is down-regulated during
myelination and by Krox20, and plays an important role in
demyelination in injured nerves (Mirsky et al., 2008; Woodhoo
et al., 2009). For this reason, the up-regulation of negative
regulators of the Notch pathway is difficult to explain, unless we
hypothesise that Notch is up-regulated in a different time point
or that Notch expression is regulated at protein level, or that the
genes grouped in this gene ontology category actually contribute
to demyelination and Schwann cell de-differentiation without
inhibiting Notch pathway. Indeed, Bmp7 retards peripheral
myelination by activating p38 MAPK in Schwann cells (Liu et al.,
2016), while delta like non-canonical Notch ligand 1 (Dlk1) and
Delta-like 4 Notch ligand (Dll4) are both Notch ligands.
Since NRG1 is strongly up-regulated after injury and
Schwann cells represent a high percentage of cells in the
injured nerve, we hypothesised that their contribution to the
injured nerve transcriptome is relevant. Therefore, we compared
the list of genes regulated in Schwann cells in response to
NRG1 stimulation with the lists of genes regulated after nerve
injury, with the idea to identify, amongmany regulated genes, the
genes regulated in Schwann cells following NRG1 stimulation.
To this aim, we exploited previously published expression
profiling data of injured sciatic nerves at different early time
points (0.5, 1, 6, 12 h and 1, 3, 5, 7 days) following injury (Barrette
et al., 2010; Kim et al., 2012; Yi et al., 2017). These data were
obtained using microarray assay; more recently, deep sequencing
data at 7 days after injury were published and made available
to the scientific community (Arthur-Farraj et al., 2017). Thus,
in Figure 4, we show two data set corresponding to 7 days
after injury; they do not correspond 100%, likely because the
first set derives from a microcrushed nerve, the second from a
transected nerve; moreover, the first was analysed by microarray,
the second was analysed by deep sequencing. Accordingly, the
authors of the latter analysis compared their deep sequencing
analysis with a previous microarray analysis (Arthur-Farraj et al.,
2012), finding that ∼20% of regulated genes were differently
regulated. As expected, several genes that are regulated by
NRG1 in Schwann cells overlap with genes regulated in the
sciatic nerve following nerve injury. Nevertheless, some genes
show a different regulation. These differences can be explained
by the fact that genes expressed in injured sciatic nerves belong
mainly to Schwann cells, but also to other cell types, while
the gene expression profile obtained with the deep sequencing
corresponds to genes expressed only by Schwann cells. Moreover,
in the injured nerve environment several factors are released, not
only soluble NRG1, and the nerve analysis reveals genes regulated
by different factors.
Ex vivo primary cultures represent a good experimental
model as they allow focusing the analysis on a single cell type
(e.g., Schwann cells), while in vivo different cell types coexist
in the injured nerve: Schwann cells, fibroblasts, macrophages,
epineural cells, and so on.Moreover, they allow analysing a single
factor stimulation (e.g., NRG1), while in vivo different factors are
released after injury.
Our in vitro analysis focused on genes regulated after 6 h
stimulation; we chose this time point because we were interested
to identify genes regulated early by NRG1 in Schwann cells.
Indeed, in vivo experiments showed that after nerve injury
NRG1mRNA increase is detectable between 1 h and 24 h (Carroll
et al., 1997; Stassart et al., 2013; Ronchi et al., 2016; Yu et al., 2016)
and several genes start to be differentially expressed between
6 h and 24 h (Yi et al., 2017).
By comparing the differentially expressed genes in Schwann
cells after in vitroNRG1 stimulation with differentially expressed
genes in peripheral nerves in response to injury, we found that
many genes show the same behaviour in the two experimental
models (40% up- and 54% down-regulated) while only 11% show
an opposite behaviour. As previously discussed, this opposite
behaviour might be explained by the fact that the expression
of these genes in the peripheral nerve is not regulated in
Schwann cells, but rather in other cell types belonging to
the nerve tissue, or by the fact that the expression of these
genes in injured Schwann cells is also regulated by other
factors released in the injured environment. Among them,
we noticed the transcription factors Atf3 and Fos (Patodia
and Raivich, 2012) and Gadd45a (Lin et al., 2011), which are
significantly down-regulated by NRG1 in Schwann cells in vitro,
while in vivo are up-regulated in sciatic nerves (Arthur-Farraj
et al., 2017) and dorsal root ganglia (DRG) neurons after
injury.
First, we compared genes differentially expressed in vitro
in NRG1 stimulated Schwann cells with genes differentially
expressed in vivo a few hours after nerve injury (0.5–12 h). In the
early hours we found more up-regulated than down-regulated
common genes. Four of them (Il11, Phlda1, Slc6a17, Vgf) are
up-regulated in the first 12–24 h only, thus suggesting that they
may play a role immediately after injury.
Then, we focused our attention on up-regulated and
down-regulated genes common to all time points (from day
1 until day 7) following nerve injury and following Schwann
cell NRG1 stimulation. In this time window, we found more
down-regulated than up-regulated common genes.
A common up-regulated gene is Ubiquitin Like with PHD
and Ring Finger Domains 1 (Uhrf1), encoding for a E3 ubiquitin
ligase. This protein binds to specific DNA sequences, regulating
gene expression. It has been shown that Uhrf1 plays a role in
inducing basal cell proliferation following airway injury (Xiang
et al., 2017), thus suggesting that it might play a similar role in
stimulating proliferation of Schwann cells following a peripheral
nerve injury.
Another common up-regulated gene is Lamin B1 (Lmnb1),
playing an important role in the modulation of genes involved
in normal myelin regulation; moreover, Lmnb1 over-expression
is associated with down-regulation of proteolipid protein, a
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highly abundant myelin sheath component (Heng et al., 2013).
Intriguingly, another gene regulated at all time points after
injury and after NRG1 stimulation is FXYD domain containing
ion transport regulator 5 (Fxyd5), which has been recently
shown to be a regeneration-associated gene (RAG), whose
over-expression increases (and knock-down decreases) neuritis
length and number (Chandran et al., 2016).
The common down-regulated genes include Cldn19, Ephx1,
Wnt6 and Fa2h.
Tight-Junction Gene Claudin 19 (Cldn19) is the main tight
junction constituent of Schwann cells and it is involved in their
electrophysiological sealing function (Miyamoto et al., 2005) in
the healthy nerve. Microsomal epoxide hydrolase (Ephx1) is an
evolutionarily highly conserved enzyme expressed in nearly all
tissues, where it can play a role in redox homeostasis by removing
reactive oxygen species (Václavíková et al., 2015). Abnormalities
in Ephx1 expression are involved in neurological disorders such
as Alzheimer’s disease (Liu et al., 2006) and tumours. As far as
we know, nothing was mentioned in literature about its role in
peripheral nerves or Schwann cells.
Wnt is expressed by axons, and it has been found that
Wnt signalling promotes Schwann cell lineage progression,
proliferation and myelination (Grigoryan et al., 2013).
Fatty acid 2-hydroxylase (Fa2h), which is down-regulated
from the first till the 7th day post injury, is found to be directly
related to the process of myelin formation, where it is required
for the synthesis of 2-hydroxy galactolipids in peripheral nerve
myelin (Maldonado et al., 2008).
Other genes that are down-regulated by NRG1 and related
to the myelination process (Mal, Ndrg1, Pmp22, Egr2, Rxrg)
are also down-regulated at different time points after injury,
suggesting that NRG1 might be involved in the demyelination
process following nerve injury.
The down-regulation of genes involved in the myelination is
particularly intriguing in the light of our recent data obtained
from a rat model of the demyelinating neuropathy Charcot-
Marie-Tooth 1A, where we demonstrated that soluble NRG1 is
strongly over-expressed in the nerves (Fornasari et al., 2018).
We wondered if soluble NRG1 over-expression worsens
the disease or counteracts it, attenuating its symptoms and
promoting nerve repair. The down-regulation of myelination
genes suggests that it worsens the disease and that therapeutic
approaches aimed to inhibit NRG1 activity could be more
useful than therapeutic approaches involving treatment
with soluble NRG1 (Fledrich et al., 2014). Accordingly,
it has been shown that a high concentration of soluble
NRG1 negatively affects in vitro myelination (Syed et al.,
2010).
Our in vitro analysis shows that soluble NRG1 plays a key role
for Schwann cell survival, de-differentiation and demyelination,
thus suggesting that in vivo, after peripheral nerve injury,
soluble NRG1 release or delivery needs to be limited to the
early phases after nerve injury. Indeed, in the following phases,
the remyelination is promoted by the NRG1 transmembrane
isoforms expressed by the axons (Michailov et al., 2004; Taveggia
et al., 2005).
This concept must be kept in mind when planning gene
therapies with soluble NRG1 or recombinant factor delivery
aimed to promote peripheral nerve regeneration.
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